# Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

> **NCT04533243** · PHASE3 · UNKNOWN · sponsor: **Fujian Cancer Hospital** · enrollment: 209 (estimated)

## Conditions studied

- Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive

## Interventions

- **DRUG:** 2.5ug/h transdermal fentanyl
- **DRUG:** Oral immediate-released morphine

## Key facts

- **NCT ID:** NCT04533243
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 209 (ESTIMATED)
- **Last updated:** 2020-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04533243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04533243, "Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04533243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*